Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

Boiron, Louis; A. Joura, Elmar; Largeron, Nathalie; Prager, Bernhard; Uhart, M.

doi:10.1186/s12879-016-1483-5

Public

Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

Published in BMC Infectious Diseases • Apr 15, 2016

Authors:

Louis Boiron

Elmar A. Joura

Nathalie Largeron

Abstract

BACKGROUND: HPV is a major cancer-causing factor in both sexes in the cervix, vulva, vagina, anus, penis, oropharynx as well as the causal factor in other diseases such as genital warts and recurrent respiratory papillomatis. In the context of the arrival of a nonavalent HPV vaccine (6/11/16/18/31/3...

Subject

Medicine

Genital warts

Vaccination

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!